B. Bengtsson

发表

L. Aarvik, B. Bengtsson, Hallvard Elven, 2017 .

Detection of growth hormone abuse in sport.

P. Sönksen, R. Napoli, L. Saccá, 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Effects of growth hormone treatment on the leptin system and on energy expenditure in abdominally obese men.

P. Björntorp, L. Sjöström, B. Bengtsson, 1998, European journal of endocrinology.

Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters.

S. Lindstedt, S. Lindstedt, A. Lindahl, 1995, Neuroendocrinology.

Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy

J. Svensson, L. Rylander, M. Thorén, 2013, Psychoneuroendocrinology.

GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety

B. Bengtsson, J. Tauber, C. Wüster, 1999, Clinical endocrinology.

Possible Protective Role of Growth Hormone in Hypoxia-Ischemia in Neonatal Rats

C. Brantsing, H. Hagberg, B. Bengtsson, 1999, Pediatric Research.

Psychological Well-Being in Growth Hormone Deficiency and Central Nervous Effects of Growth Hormone

B. Bengtsson, J. Johansson, 1999 .

Growth Hormone Deficiency in Adulthood and the Effects of Growth Hormone Replacement: A Review

P. Carroll, P. Sönksen, E. Christ, 1998 .

The use of growth hormone in adults: a review of the last 10 years, the present and a perspective for the future.

B. Bengtsson, G. Johannsson, 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Growth hormone deficiency in adults: a new indication for recombinant human growth hormone

B. Bengtsson, 1996, Journal of Internal Medicine.

Fifteen years of GH replacement improves body composition and cardiovascular risk factors

J. Svensson, B. Bengtsson, G. Johannsson, 2013, European journal of endocrinology.

Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency

J. Svensson, B. Bengtsson, G. Johannsson, 2011, European journal of endocrinology.

P23 Effects of 3-year growth hormone (GH) replacement therapy on bone mineral density in younger and elderly adults with adult onset GH deficiency

J. Svensson, B. Bengtsson, G. Johannsson, 2010 .

Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.

J. Svensson, B. Bengtsson, G. Johannsson, 2006, The Journal of clinical endocrinology and metabolism.

GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhood.

A. Iranmanesh, J. Svensson, B. Bengtsson, 2006, European journal of endocrinology.

Effects of GH and insulin-like growth factor-I on body composition

L. Lönn, J. Svensson, B. Bengtsson, 2003, Journal of endocrinological investigation.

How Sex Steroids Modulate GH Action on Target Tissues: Long-Term Follow-up in GH-Deficient Adults

B. Bengtsson, G. Johannsson, 1999 .

Clinical and Experimental Effects of Growth Hormone Secretagogues on Various Organ Systems

J. Svensson, B. Bengtsson, 1999, Hormone Research in Paediatrics.

Insulin‐like growth factor‐I in growth hormone‐deficient adults: relationship to population‐based normal values, body composition and insulin tolerance test

J. Svensson, B. Bengtsson, G. Johannsson, 1997, Clinical endocrinology.

Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults

B. Bengtsson, T. Rosén, G. Johannsson, 1997, Clinical endocrinology.

Long‐term cardiovascular effects of growth hormone treatment in GH‐deficient adults Preliminary data in a small group of patients

K. Caidahl, B. Bengtsson, G. Johannsson, 1996, Clinical endocrinology.

The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender.

M. Thorén, B. Bengtsson, L. Carlsson, 1996, The Journal of clinical endocrinology and metabolism.

Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus.

P. Björntorp, L. Mattsson, B. Bengtsson, 1997, The Journal of clinical endocrinology and metabolism.

Growth hormone secretion after testosterone administration to men with visceral obesity.

P. Björntorp, R. Rosmond, B. Bengtsson, 1994, Obesity research.

Visceral obesity and the role of the somatotropic axis in the development of metabolic complications.

B. Bengtsson, G. Johannsson, C. Franco, 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Serum leptin concentration and insulin sensitivity in men with abdominal obesity.

L. Lönn, P. Björntorp, L. Sjöström, 1998, Obesity research.

The effect of metoprolol treatment on insulin sensitivity and diurnal plasma hormone levels in hypertensive subjects

M. Elam, P. Lönnroth, S. Gudbjörnsdottir, 1997, European journal of clinical investigation.

Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society.

S. Hankinson, D. Yee, I. Robinson, 2001, The Journal of clinical endocrinology and metabolism.

Acromegaly and Neoplasia

B. Bengtsson, 1993, The Journal of pediatric endocrinology.

Body composition and tissue distributions in growth hormone deficient adults before and after growth hormone treatment.

L. Lönn, L. Sjöström, B. Bengtsson, 1996, Obesity research.

Cost of Illness in Adult Patients with Hypopituitarism

B. Bengtsson, T. Rosén, F. Rutten, 2000, PharmacoEconomics.

Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.

J. A. Scarlett, L. Phillips, M. Vance, 2000, The New England journal of medicine.

Growth hormone and the metabolic syndrome.

B. Bengtsson, G. Johannsson, 1999, Journal of endocrinological investigation.

Growth Hormone Increases Bone Mineral Content in Postmenopausal Osteoporosis: A Randomized Placebo‐Controlled Trial

I. Bosaeus, B. Bengtsson, A. Nilsson, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.

B. Bengtsson, G. Johannsson, F. Karlsson, 2002, The Journal of clinical endocrinology and metabolism.

Evaluation of different methods of determining body composition, with special reference to growth hormone-related disorders.

B. Bengtsson, T. Rosén, R. Brummer, 1993, Acta endocrinologica.

GH effect on enzyme activity of 11 b HSD in abdominal obesity is dependent on treatment duration

B. Bengtsson, G. Johannsson, J. Koranyi, 2005 .

Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: I. Effects on insulin-like growth factor-I (IGF-I), GH and IGF binding proteins, and glucose homeostasis.

B. Bengtsson, R. Bjarnason, J. Oscarsson, 1996, Metabolism: clinical and experimental.

Growth hormone-deficient adults are insulin-resistant.

B. Bengtsson, I. Lager, J. Johansson, 1995, Metabolism: clinical and experimental.

Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial.

B. Bengtsson, G. Johannsson, I. Pávó, 2002, The Journal of clinical endocrinology and metabolism.

Hormones, body composition and cardiovascular risk.

L. Lönn, L. Sjöström, M. Alpsten, 1995, Asia Pacific journal of clinical nutrition.

Effect of prolonged hyperglycemia on growth hormone levels and insulin sensitivity in insulin-dependent diabetes mellitus.

U. Smith, H. von Schenck, B. Bengtsson, 1993, Metabolism: clinical and experimental.

Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.

B. Bengtsson, I. Lager, S. Attvall, 1993, Metabolism: clinical and experimental.

Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement.

B. Bengtsson, G. Johannsson, J. Ahlmén, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport.

H. Orskov, P. Sönksen, R. Baxter, 1999, The Journal of clinical endocrinology and metabolism.

Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy.

M. Buchfelder, B. Bengtsson, G. Johannsson, 2009, European journal of endocrinology.

Premature mortality due to cardiovascular disease in hypopituitarism

B. Bengtsson, T. Rosén, B. Bengtsson, 1990, The Lancet.

Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density

B. Bengtsson, U. Feldt-Rasmussen, S. Sørensen, 2007, Genetics in Medicine.

Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study

P. Svensson, I. Bosaeus, B. Bengtsson, 2014, PloS one.

Giant cell arteritis. Epidemiology and treatment.

B. Bengtsson, E. Nordborg, R. Andersson, 1994, Drugs & aging.

The Influence of Growth Hormone Deficiency, Growth Hormone Replacement Therapy, and Other Aspects of Hypopituitarism on Fracture Rate and Bone Mineral Density

B. Bengtsson, U. Feldt-Rasmussen, C. Wüster, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.

B. Bengtsson, L. Carlsson, C. Boguszewski, 2009, The Journal of clinical endocrinology and metabolism.

Diurnal variations in twenty-four-hour energy expenditure during growth hormone treatment of adults with pituitary deficiency.

L. Lönn, L. Sjöström, B. Bengtsson, 1997, The Journal of clinical endocrinology and metabolism.

Effect of growth hormone treatment on circulating levels of NT-proBNP in patients with ischemic heart failure.

K. Swedberg, E. Bollano, K. Karason, 2020, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Giant Cell Arteritis

B. Bengtsson, E. Nordborg, R. Andersson, 1994, Rheumatic diseases clinics of North America.

Epidemiology of biopsy‐proven giant cell arteritis (GCA)

B. Bengtsson, E. Nordborg, 1990, Journal of internal medicine.

Supraphysiological doses of GH induce rapid changes in cardiac morphology and function.

R. Napoli, L. Saccá, K. Caidahl, 2002, The Journal of clinical endocrinology and metabolism.

Acute phase reactants in the initial phase of giant cell arteritis.

B. Bengtsson, B. Malmvall, R. Andersson, 2009, Acta medica Scandinavica.

Plasma viscosity in giant cell arteritis as a predictor of disease activity.

B. Bengtsson, A. Bjelle, E. Nordborg, 1993, Annals of the rheumatic diseases.

Giant cell arteritis. Clinical features and involvement of different organs.

B. Bengtsson, B. Malmvall, 1978, Scandinavian journal of rheumatology.

Giant cell arteritis as a cause of death. Report of nine cases.

B. Bengtsson, B. Malmvall, R. Andersson, 1986, JAMA.

Enzyme replacement in Anderson-Fabry disease

B. Bengtsson, G. Linthorst, J. Johansson, 2003, The Lancet.

Safety aspects of GH replacement.

J. Svensson, B. Bengtsson, 2009, European journal of endocrinology.

Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.

J. Svensson, B. Bengtsson, J. Johansson, 2002, The Journal of clinical endocrinology and metabolism.

Life expectancy in patients with pituitary adenoma receiving growth hormone replacement.

I. Bryngelsson, T. Skoglund, B. Bengtsson, 2017, European journal of endocrinology.

Are lens opacities related to plasma selenium and glutathione peroxidase in man?

B. Bengtsson, B. Steen, B. Åkesson, 1987, Experimental eye research.

Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy.

B. Bengtsson, E. Nordborg, 1989, BMJ.

The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications.

B. Bengtsson, B. Malmvall, 1981, Arthritis and rheumatism.

Growth hormone alone or combined with metoprolol preserves cardiac function after myocardial infarction in rats

E. Bollano, E. Omerovic, F. Waagstein, 2001, European journal of heart failure.

Growth hormone replacement therapy and insulin sensitivity.

J. Svensson, B. Bengtsson, 2003, The Journal of clinical endocrinology and metabolism.

Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy.

M. Thorén, B. Bengtsson, T. Rosén, 1995, European journal of endocrinology.

The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.

B. Bengtsson, U. Feldt-Rasmussen, C. Wüster, 1999, The Journal of clinical endocrinology and metabolism.

Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency.

E. Ghigo, R. Baxter, M. Irie, 1998, The Journal of clinical endocrinology and metabolism.

Growth hormone and ageing.

J. Svensson, B. Bengtsson, G. Johannsson, 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Discontinuation of Growth Hormone (GH) Treatment: Metabolic Effects in GH-Deficient and GH-Sufficient Adolescent Patients Compared with Control Subjects*

B. Bengtsson, G. Johannsson, K. Albertsson-Wikland, 1999 .

Cardiovascular and renal effects of growth hormone *

K. Caidahl, B. Bengtsson, S. Edén, 1994, Clinical endocrinology.

Increased Number of Retinal Vessels in Acromegaly.

B. Bengtsson, G. Johannsson, A. Hellstrom, 2020, European journal of endocrinology.

Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up.

M. Buchfelder, M. Jarfelt, B. Bengtsson, 2012, European journal of endocrinology.

Serum insulin‐like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin

B. Bengtsson, P. Lundberg, T. Rosén, 1994, Clinical endocrinology.

BODY COMPOSITION IN ACROMEGALY: THE EFFECT OF TREATMENT

I. Bosaeus, R. Brummer, B. Bengtsson, 1989, Clinical endocrinology.

Altered lipid pattern explains increased cardiovascular mortality in hypopituitary patients with growth hormone deficiency

B. Bengtsson, T. Rosén, L. Wilhelmsen, 1998, Clinical endocrinology.

Not only growth hormone (GH)-deficient men are more responsive to GH than women.

B. Bengtsson, G. Johannsson, R. Brummer, 1997, The Journal of clinical endocrinology and metabolism.

Currently used growth‐promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents ‡

I. Bosaeus, B. Bengtsson, G. Johannsson, 2001, Clinical endocrinology.

Growth Hormone Treatment in Experimental Heart Failure

B. Bengtsson, J. Isgaard, 2001 .

EXPERIMENTAL HEART FAILURE

B. Bengtsson, J. Isgaard, 2001 .

T. Hedner, K. Caidahl, B. Bengtsson, 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

T. Hedner, E. Bollano, K. Caidahl, 2022 .

GH and the heart: potential therapeutic use.

B. Bengtsson, J. Isgaard, 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Use of Growth Hormone for Treatment of Anatomic and Physiologic Decrements Associated with Aging

B. Bengtsson, G. Johannsson, J. Isgaard, 1998 .

A comparison of different methods to measure body composition in patients.

M. Alpsten, I. Bosaeus, B. Bengtsson, 1998, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Increased body fat mass and decreased extracellular fluid volume in adults with growth hormone deficiency

I. Bosaeus, B. Bengtsson, T. Rosén, 1993, Clinical endocrinology.

Cardiovascular risk factors in adult patients with growth hormone deficiency.

L. Wilhelmsen, B. Bengtsson, T. Rosén, 1993, Acta endocrinologica.

Effects of growth hormone on fat mass and fat distribution.

L. Sjöström, B. Bengtsson, T. Rosén, 1992, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Assimilation of triglycerides in subcutaneous and intraabdominal adipose tissues in vivo in men: effects of testosterone.

L. Lönn, P. Björntorp, B. Bengtsson, 1996, The Journal of clinical endocrinology and metabolism.

Serum lipoproteins in acromegaly before and 6‐15 months after transsphenoidal adenomectomy

O. Wiklund, B. Bengtsson, J. Oscarsson, 1994, Clinical endocrinology.

Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group.

S. Lamberts, B. Bengtsson, C. Strasburger, 1997, The Journal of clinical endocrinology and metabolism.

Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency

M. M. Ilondo, J. Svensson, M. Korbonits, 2003, Clinical endocrinology.

Increased orderliness of growth hormone (GH) secretion in GH-deficient adults with low serum insulin-like growth factor I.

A. Iranmanesh, J. Svensson, B. Bengtsson, 2002, The Journal of clinical endocrinology and metabolism.

GH and bone--experimental and clinical studies.

C. Ohlsson, B. Bengtsson, G. Johannsson, 2000, Endocrine journal.

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.

P. Carroll, P. Sönksen, E. Christ, 1998, The Journal of clinical endocrinology and metabolism.

Osteoporosis after long‐term corticosteroid treatment of giant cell arteritis

D. Mellström, B. Bengtsson, Å. Rundgren, 1990, Journal of internal medicine.

Giant cell and Takayasu's arteritis.

B. Bengtsson, R. Andersson, 1991, Current opinion in rheumatology.

Long-term corticosteroid treatment in giant cell arteritis.

B. Bengtsson, B. Malmvall, R. Andersson, 2009, Acta medica Scandinavica.

Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults

L. Ellegård, I. Bosaeus, B. Bengtsson, 2005, Clinical endocrinology.

Growth hormone and the acquisition of bone mass.

B. Bengtsson, G. Johannsson, 1997, Hormone research.

Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes.

L. Ellegård, K. Caidahl, B. Bengtsson, 2005, The Journal of clinical endocrinology and metabolism.

Growth hormone in adults: Growth hormone and psychosocial and central nervous effects

B. Bengtsson, J. Johansson, L. Wíren, 2000 .

Reduced bone mineral content in adult patients with growth hormone deficiency.

T. Hansson, B. Bengtsson, T. Rosén, 1993, Acta endocrinologica.

Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids.

B. Bengtsson, B. Malmvall, R. Andersson, 2009, Acta medica Scandinavica.

Intraocular pressure changes and alterations in intracranial pressure

P. Delmas, C. Ohlsson, B. Bengtsson, 2000 .

Growth hormone deficiency and replacement in elderly hypopituitary adults

M. Thorén, B. Bengtsson, C. Wüster, 2000, Clinical endocrinology.

Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism.

B. Bengtsson, 1998, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper.

B. Bengtsson, T. Rosén, G. Johannsson, 1995, Hormone research.

Cardiovascular effects of GH.

L. Saccá, B. Bengtsson, J. Christiansen, 1997, The Journal of endocrinology.

The effects of five‐year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients

J. Svensson, K. Sunnerhagen, B. Bengtsson, 2005, Clinical endocrinology.

Insulin‐like growth factor‐1 is a predictor of blood haemoglobin concentration in 70‐yr‐old subjects

D. Mellström, B. Bengtsson, G. Lindstedt, 2005, European journal of haematology.

Treatment with the Oral Growth Hormone Secretagogue MK‐677 Increases Markers of Bone Formation and Bone Resorption in Obese Young Males

S. Mohan, C. Ohlsson, J. Svensson, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test.

R. Baxter, R. Napoli, B. Bengtsson, 2003, The Journal of clinical endocrinology and metabolism.

Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.

S. Mohan, C. Ohlsson, B. Bengtsson, 2007, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults.

B. Bengtsson, T. Rosén, L. Tengborn, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Consequences of Growth Hormone Deficiency (GHD) in Adults and the Effects of Replacement Therapy with Recombinant Human Growth Hormone (rhGH)

B. Bengtsson, T. Rosén, G. Johannsson, 1994 .

Postmenopausal osteoporosis is more related to hormonal aberrations than to lifestyle factors

L. Wilhelmsen, B. Bengtsson, B. Bengtsson, 1999, Clinical endocrinology.

Effect of growth-hormone therapy on early atherosclerotic changes in GH-deficient adults

B. Bengtsson, G. Johannsson, 1999, The Lancet.

AACE CLINICAL PRACTICE GUIDELINES FOR GROWTH HORMONE USE IN ADULTS AND CHILDREN

H. Gharib, H. Rodbard, J. J. Janick, 1999 .

Four years of growth hormone replacement in adults with growth hormone deficiency: further increase in bone mineral density

B. Bengtsson, T. Rosén, G. Johannsson, 1998 .

The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.

P. Sönksen, R. Baxter, R. Napoli, 2000, The Journal of clinical endocrinology and metabolism.

Growth hormone reduces inflammation in postmenopausal women with abdominal obesity: a 12-month, randomized, placebo-controlled trial.

L. Lönn, J. Svensson, B. Bengtsson, 2007, The Journal of clinical endocrinology and metabolism.

The prevalence of radiographic osteoarthritis is low in elderly patients with growth hormone deficiency.

B. Bengtsson, T. Rosén, E. Bagge, 1993, Acta endocrinologica.

Body Composition and Quality of Life as Markers of the Efficacy of Growth Hormone Replacement Therapy in Adults

J. Svensson, B. Bengtsson, G. Johannsson, 2001, Hormone Research in Paediatrics.

Effects of growth hormone and its secretagogues on bone

C. Ohlsson, J. Svensson, J. Jansson, 2001, Endocrine.

The effect of treatment with the oral growth hormone (GH) secretagogue MK-677 on GH isoforms.

J. Svensson, B. Bengtsson, L. Carlsson, 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The GH secretagogues ipamorelin and GH-releasing peptide-6 increase bone mineral content in adult female rats.

C. Ohlsson, J. Svensson, J. Jansson, 2000, The Journal of endocrinology.

T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis.

R. Jonsson, B. Bengtsson, A. Tarkowski, 1987, Annals of the rheumatic diseases.

arteritis . patients with giant cell markers in the arterial walls of of immunological activation T cell subsets and expression

R. Jonsson, B. Bengtsson, A. Tarkowski, 2022 .

Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study on ninety patients treated with corticosteroids.

B. Bengtsson, B. Malmvall, 2009, Acta medica Scandinavica.

Fracture Incidence in GH‐Deficient Patients on Complete Hormone Replacement Including GH

J. Svensson, L. Hagmar, L. Rylander, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Continuous 24‐hour secretion of growth hormone during late pregnancy

B. Bengtsson, S. Edén, B. Schoultz, 1988, Acta obstetricia et gynecologica Scandinavica.

The role of the GH/IGF-I axis for cardiac function and structure.

B. Bengtsson, J. Isgaard, Å. Tivesten, 1999, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Growth Hormone Replacement Therapy Is Not Associated with Any Increase in Mortality

B. Bengtsson, 1999 .

Muscle strength in patients with acromegaly at diagnosis and during long-term follow-up.

K. Sunnerhagen, B. Bengtsson, G. Johannsson, 2017, European journal of endocrinology.

Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

L. Lönn, B. Bengtsson, G. Johannsson, 2005, The Journal of clinical endocrinology and metabolism.

Hypopituitarism—needs modern individualized treatment

B. Bengtsson, Daniel S Olsson, 2017, Endocrine.

Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation.

J. Svensson, B. Bengtsson, G. Johannsson, 2013, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults - a KIMS database analysis.

M. Kołtowska-Häggström, B. Bengtsson, U. Feldt-Rasmussen, 2006, European journal of endocrinology.

American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children--2003 update.

H. Gharib, H. Rodbard, M. Vance, 2003, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Premature mortality and hypopituitarism

L. Hagmar, B. Bengtsson, E. Erfurth, 2001, The Lancet.

Growth Hormone Therapy in GH-Deficient Adults: The Problem of the Dose—Authors’ Response1

B. Bengtsson, G. Johannsson, D. Ph, 1997 .

Long-term Treatment with Growth Hormone Decreases Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator in Growth Hormone-deficient Adults

B. Bengtsson, G. Johannsson, L. Tengborn, 1996, Thrombosis and Haemostasis.

Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.

B. Bengtsson, M. Bramnert, C. Wüster, 2002, European journal of endocrinology.

Growth hormone abuse.

B. Bengtsson, T. Rosén, C. Ehrnborg, 2000, Bailliere's best practice & research. Clinical endocrinology & metabolism.

Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome.

L. Ellegård, I. Bosaeus, B. Bengtsson, 1997, Annals of surgery.

Circulating non-22-kilodalton growth hormone isoforms in acromegalic men before and after transsphenoidal surgery.

B. Bengtsson, L. Carlsson, C. Boguszewski, 1997, The Journal of clinical endocrinology and metabolism.

Effects of Growth Hormone on Body Composition and Metabolism

B. Bengtsson, S. Edén, J. Oscarsson, 1990, Acta paediatrica Scandinavica. Supplement.

Consequences of growth hormone deficiency in adults, and effects of growth hormone replacement therapy

B. Bengtsson, T. Rosén, G. Johannsson, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Treatment of adults with growth hormone (GH) deficiency with recombinant human GH.

L. Lönn, L. Sjöström, I. Bosaeus, 1993, The Journal of clinical endocrinology and metabolism.

Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency.

J. Svensson, B. Bengtsson, G. Johannsson, 2017, European journal of endocrinology.

THERAPEUTIC CONTROVERSY Treatment of Growth Hormone Deficiency in Adults

B. Bengtsson, G. Johannsson, S. Shalet, 2000 .

Effects of recombinant human growth hormone on adipose tissue in adults with growth hormone deficiency

L. Lönn, B. Bengtsson, T. Rosén, 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery.

B. Bengtsson, P. Lundberg, K. Albertsson-Wikland, 1989, Acta endocrinologica.

A placebo-controlled study of growth hormone in patients with congestive heart failure.

M. Lomsky, K. Caidahl, B. Bengtsson, 1998, European heart journal.

CT-determined body composition changes with recombinant human growth hormone treatment to adults with growth hormone deficiency.

L. Lönn, L. Sjöström, B. Bengtsson, 1993, Basic life sciences.

An alternate-day corticosteroid regimen in maintenance therapy of giant cell arteritis.

B. Bengtsson, B. Malmvall, 2009, Acta medica Scandinavica.

Premature death in patients operated on for primary hyperparathyroidism

B. Bengtsson, A. Odén, I. Hedman, 1990, World Journal of Surgery.

Growth hormone replacement therapy is not associated with any increase in mortality. KIMS Study Group.

B. Bengtsson, H. Koppeschaar, U. Feldt-Rasmussen, 1999, The Journal of clinical endocrinology and metabolism.

Serum levels of immunoglobulin and complement in giant-cell arteritis.

B. Bengtsson, K. Alestig, L. Nilsson, 1976, JAMA.

Giant cell arteritis.

C. Nordborg, B. Bengtsson, E. Nordborg, 1990, Current opinion in rheumatology.

HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis.

R. Jonsson, G. Hansson, B. Bengtsson, 1988, Clinical and experimental immunology.

Comparison of different body composition models in acromegaly.

L. Lönn, L. Sjöström, I. Bosaeus, 1996, Growth regulation.

Growth hormone and bone.

C. Ohlsson, B. Bengtsson, O. Isaksson, 1998, Endocrine reviews.

Morphological aspects of giant cells in giant cell arteritis: an electron-microscopic and immunocytochemical study.

C. Nordborg, B. Bengtsson, V. Pétursdóttir, 1997, Clinical and experimental rheumatology.

Treatment of growth hormone deficiency in adults.

B. Bengtsson, G. Johannsson, S. Shalet, 2000, The Journal of clinical endocrinology and metabolism.

Beneficial effects of long‐term GH replacement therapy on quality of life in adults with GH deficiency

B. Bengtsson, G. Johannsson, B. Bengtsson, 1998, Clinical endocrinology.

Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.

L. Lönn, L. Sjöström, P. Björntorp, 1997, The Journal of clinical endocrinology and metabolism.

Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency

J. Svensson, B. Bengtsson, G. Johannsson, 2011, European journal of endocrinology.

Order Lepidoptera Linnaeus, 1758. In : Zhang, Z.-Q. (Ed.) Animal biodiversity: An outline of higher-level classification and survey of taxonomic richness

J. Landry, I. Kitching, J. Holloway, 2011 .

Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy.

P. Svensson, B. Bengtsson, C. Boguszewski, 2012, European journal of endocrinology.

Hormone conference at Sahlgren's University Hospital: polycythemia and inappropriately high serum erythropoietin concentration in a 62-year-old man.

C. Nordborg, B. Bengtsson, P. Lundberg, 1994, Clinical chemistry.

A prospective investigation of quality of life and psychological well-being after the discontinuation of GH treatment in adolescent patients who had GH deficiency during childhood.

B. Bengtsson, G. Johannsson, L. Wíren, 2001, The Journal of clinical endocrinology and metabolism.

The GH/IGF-1 Axis in Obesity: Physiological and Pathological Aspects.

B. Bengtsson, G. Johannsson, Gudmundur Johannsson, 2006, Metabolic syndrome and related disorders.

Growth hormone replacement therapy for adults: into the new millennium.

P. Sönksen, D. Clemmons, B. Bengtsson, 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP‐6

J. Svensson, J. Jansson, L. Frohman, 1998, Clinical endocrinology.

HLA antigens in patients with giant cell arteritis, compared with two control groups of different ages.

B. Bengtsson, B. Malmvall, L. Rydberg, 1980, Scandinavian Journal of Rheumatology.

The clinical pictures of giant cell arteritis. Temporal arteritis, polymyalgia rheumatica, and fever of unknown origin.

B. Bengtsson, K. Alestig, S. Iwarson, 1980, Postgraduate medicine.

Epidemiology of giant cell arteritis.

B. Bengtsson, 1991, Bailliere's clinical rheumatology.

Temporal artery morphology and morphometry in giant cell arteritis

C. Nordborg, B. Bengtsson, E. Nordborg, 1991, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Immune complexes, rheumatoid factors, and cellular immunological parameters in patients with giant cell arteritis.

L. Bjursten, B. Bengtsson, L. Nilsson, 1981, Annals of the rheumatic diseases.

Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.

M. Kołtowska-Häggström, B. Bengtsson, U. Feldt-Rasmussen, 2005, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Transsphenoidal adenomectomy in Cushing's disease via a lateral rhinotomy approach.

B. Bengtsson, G. Lindstedt, K. Jakobsson, 1997, Surgical neurology.

Epidemiology and long-term survival in acromegaly. A study of 166 cases diagnosed between 1955 and 1984.

B. Bengtsson, A. Odén, I. Ernest, 2009, Acta medica Scandinavica.

Increased Interleukin‐6 levels in pituitary‐deficient patients are independently related to their carotid intima‐media thickness

O. Wiklund, J. Wikstrand, B. Bengtsson, 2003, Clinical endocrinology.

Growth hormone improves cardiac function in rats with experimental myocardial infarction

T. Hedner, A. Holmäng, B. Bengtsson, 1997, European journal of clinical investigation.

Decreased psychological well‐being in adult patients with growth hormone deficiency

I. Wiklund, B. Bengtsson, T. Rosén, 1994, Clinical endocrinology.

Overall and cause-specific mortality in GH-deficient adults on GH replacement.

M. Kołtowska-Häggström, B. Bengtsson, U. Feldt-Rasmussen, 2012, European journal of endocrinology.

Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency.

B. Bengtsson, A. Luger, U. Feldt-Rasmussen, 2001, The Journal of clinical endocrinology and metabolism.

Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections.

B. Bengtsson, G. Johannsson, J. Oscarsson, 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The diagnosis of growth hormone deficiency (GHD) in adults.

M. Ranke, M. Irie, B. Bengtsson, 1995, The Journal of clinical endocrinology and metabolism.

Current Status and Future Opportunities for Controlling Acromegaly

M. Vance, S. Melmed, A. Klibanski, 2004, Pituitary.

Five-year follow-up of nonsecreting pituitary adenomas.

B. Bengtsson, K. Jakobsson, B. Petruson, 1995, Archives of otolaryngology--head & neck surgery.

Giant cell arteritis.

B. Bengtsson, B. Malmvall, 1982, Acta medica Scandinavica. Supplementum.

Elevated fibrinogen levels decrease following treatment of acromegaly

L. Wilhelmsen, B. Bengtsson, B. Bengtsson, 1997, Clinical endocrinology.

Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency.

L. Sjöström, I. Bosaeus, B. Bengtsson, 1996, The Journal of clinical endocrinology and metabolism.

The consequences of growth hormone deficiency in adults.

B. Bengtsson, 1993, Acta endocrinologica.

Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults.

J. Svensson, B. Bengtsson, G. Johannsson, 2009, The Journal of clinical endocrinology and metabolism.

Intima‐media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors

J. Wikstrand, B. Bengtsson, G. Johannsson, 2002, Clinical endocrinology.

Animal biodiversity: An outline of higher-level classification and taxonomic richness

D. Wake, G. Boxshall, J. Landry, 2011 .

Validation of body composition determination by bioelectrical impedance analysis in acromegaly.

I. Bosaeus, B. Bengtsson, R. Brummer, 1992, European journal of clinical nutrition.

Patient evaluation of a new injection pen for growth hormone treatment in children and adults

M. Thorén, B. Bengtsson, G. Johannsson, 1995, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Scythris richteri sp n., a new micromoth from Croatia (Lepidoptera: Scythrididae)

B. Bengtsson, 2013 .

Growth Hormone and Syndrome X

B. Bengtsson, G. Johannsson, P. Mårin, 2000 .

Intense sympathetic nerve activity in adults with hypopituitarism and untreated growth hormone deficiency.

M. Elam, B. Bengtsson, G. Johannsson, 1998, The Journal of clinical endocrinology and metabolism.

The scythridid fauna of the southern Ural Mountains, with description of fourteen new species (Lepidoptera: Scythrididae)

B. Bengtsson, V. Olschwang, K. Nupponen, 2000 .

New for the Polish fauna and rare Microlepidoptera [Lepidoptera] from the Bialowieza Forest

B. Bengtsson, T. Baran, O. Karsholt, 2001 .

A revision of the Elachista regificella Sircom -complex (Lepidoptera: Elachistidae)

B. Bengtsson, L. Kaila, J. Junnilainen, 2001 .

BODY COMPOSITION IN ACROMEGALY

I. Bosaeus, B. Bengtsson, S. Edén, 1989, Clinical endocrinology.

Thrombokinetics in giant cell arteritis, with special reference to corticosteroid therapy.

B. Bengtsson, B. Malmvall, J. Kutti, 1979, Annals of the rheumatic diseases.

Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.

J. Svensson, B. Bengtsson, T. Rosén, 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Body composition during GH replacement in adults - methodological variations with respect to gender.

M. Alpsten, I. Bosaeus, B. Bengtsson, 2006, European journal of endocrinology.

Bone mineral content of the third lumbar vertebra during 18 months of prednisolone treatment for giant cell arteritis

T. Hansson, B. Bengtsson, R. Jonson, 1993, Clinical Rheumatology.

Nonfatal stroke, cardiac disease, and diabetes mellitus in hypopituitary patients on hormone replacement including growth hormone.

B. Norrving, J. Svensson, L. Hagmar, 2007, The Journal of clinical endocrinology and metabolism.

Growth hormone replacement therapy induces codeine clearance

B. Bengtsson, G. Johannsson, A. Rane, 2002, European journal of clinical investigation.

High correlation between quantitative ultrasound and DXA during 7 years of follow-up.

I. Bosaeus, B. Bengtsson, K. Landin-Wilhelmsen, 2010, European journal of radiology.

Chapter 15 – GHRP-s in Human Obesity

J. Svensson, J. Jansson, B. Bengtsson, 1999 .

Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males.

P. Sönksen, L. Saccá, B. Bengtsson, 2000, The Journal of clinical endocrinology and metabolism.

Two years of growth hormone (GH) treatment increase isometric and isokinetic muscle strength in GH-deficient adults.

G. Grimby, K. Sunnerhagen, B. Bengtsson, 1997, The Journal of clinical endocrinology and metabolism.

Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and I year after adenomectomy

L. Sjöström, B. Bengtsson, H. Kvist, 1993, European journal of clinical investigation.

Growth hormone and body composition.

I. Bosaeus, B. Bengtsson, R. Brummer, 1990, Hormone research.

Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement.

Johan Svensson, J. Svensson, B. Bengtsson, 2010, European journal of endocrinology.

Inhibition of cortisol secretion by dexamethasone in relation to body fat distribution: a dose-response study.

P. Björntorp, B. Bengtsson, P. Mårin, 1996, Obesity research.

Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity.

L. Lönn, A. Iranmanesh, J. Svensson, 2006, European journal of endocrinology.

Diurnal variation in serum insulin‐like growth factor (IGF)‐I and IGF binding protein‐3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH‐deficient adults

B. Bengtsson, P. Lundberg, G. Johannsson, 1997, Clinical endocrinology.

von Willebrand factor antigen and plasminogen activator inhibitor in giant cell arteritis.

B. Bengtsson, L. Tengborn, S. Edén, 1991, Annals of the rheumatic diseases.

Comparison of methods to estimate body fat in growth hormone deficient adults

L. Sjöström, I. Bosaeus, B. Bengtsson, 1996, Clinical endocrinology.

Effect of recombinant human growth hormone on cellular sodium metabolism.

B. Bengtsson, H. Herlitz, O. Jonsson, 1994, Clinical science.

The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men.

P. Björntorp, B. McEwen, J. Svensson, 2000, Obesity research.

22-kD growth hormone exclusion assay: a new approach to measurement of non-22-kD growth hormone isoforms in human blood.

B. Bengtsson, L. Carlsson, C. Boguszewski, 1996, European journal of endocrinology.

Increased fracture frequency in adult patients with hypopituitarism and GH deficiency.

L. Wilhelmsen, G. Lappas, B. Bengtsson, 1997, European journal of endocrinology.

Increased neck soft tissue mass and worsening of obstructive sleep apnea after growth hormone treatment in men with abdominal obesity.

L. Lönn, J. Svensson, J. Hedner, 2010, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality.

B. Bengtsson, B. Bengtsson, B. Jonsson, 2000, The Journal of clinical endocrinology and metabolism.

Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure.

L. Lönn, L. Sjöström, J. Svensson, 1998, The Journal of clinical endocrinology and metabolism.

Low growth hormone secretion in patients with fibromyalgia--a preliminary report on 10 patients and 10 controls.

B. Bengtsson, E. Bagge, L. Carlsson, 1998, The Journal of rheumatology.

Can growth hormone therapy cause diabetes?

B. Bengtsson, B. Bengtsson, U. Feldt-Rasmussen, 2000, The Lancet.

Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and Apo(a) and ApoE phenotypes.

L. Wilhelmsen, O. Wiklund, B. Bengtsson, 1995, Arteriosclerosis, thrombosis, and vascular biology.

Calcaneal ultrasound measurements are determined by age and physical activity. Studies in two Swedish random population samples

S. Johansson, L. Wilhelmsen, A. Rosengren, 2000, Journal of Internal Medicine.

Remarkable records of Microlepidoptera in Sweden during 2012.

B. Bengtsson, 2012 .

A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass, and metabolic indices.

M. Alpsten, J. Svensson, I. Bosaeus, 2001, The Journal of clinical endocrinology and metabolism.

Growth hormone treatment of growth hormone-deficient adults results in a marked increase in Lp(a) and HDL cholesterol concentrations.

O. Wiklund, B. Bengtsson, T. Rosén, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Epidemiology and mortality in 220 patients with polymyalgia rheumatica.

B. Bengtsson, B. Bengtsson, R. Andersson, 1995, British journal of rheumatology.

Ten years of growth hormone (GH) replacement normalizes muscle strength in GH-deficient adults.

J. Svensson, B. Bengtsson, G. Johannsson, 2009, The Journal of clinical endocrinology and metabolism.

Overall and cause-specific mortality in GH-deficient adults on GH replacement.

B. Bengtsson, U. Feldt-Rasmussen, R. Abs, 2012, European journal of endocrinology.

A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men.

M. Taskinen, J. Svensson, O. Wiklund, 2000, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Addison's disease, malignant lymphoma and death from cerebral giant cell arteritis

L. Wilhelmsen, B. Bengtsson, K. Landin, 1989, Journal of internal medicine.

Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH-deficient adults.

B. Bengtsson, C. Boguszewski, G. Johannsson, 2010, European journal of endocrinology.

Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study.

J. Svensson, K. Sunnerhagen, B. Bengtsson, 2001, The Journal of clinical endocrinology and metabolism.